PetCanSeek™
PetCanSeek™ has been developed as a first-in-class (in China) pan-cancer detection service for canines that takes a panoramic view of blood cell-free cancer signatures of canines by shallow whole genome sequencing (sWGS), equipped with proprietary AI- and big data- driven PCS (pet cancer score) algorithm, to detect the signal of cancer at an early stage.


Comprehensive
Can detect molecular cancer signals in all cancer types in canines
Non-invasive
All the test needs is only 4 ml peripheral blood from one blood draw
Multivariate PCS algorithm
The breakthrough multivariate PCS algorithm, combined with the panoramic view of cancer genome and epigenetics, accurately targets the early signals of cancer with high sensitivity
Panoramic view of cancer genome
Drawing the panoramic map of cancer genome via WGS to capture more cancer signature fingerprints
Detected at earlier cancer stage
Detecting cancer signals at microscopic molecular level to discover the hidden lesions at early stage
Product parameters
Test indicators: To assess whether the tested dog has a cancer risk by detecting the CNA of cfDNA
Sample requirements: 4ml of peripheral whole blood (non coagulation and hemolysis required)
Results presented: Defining Cancer Risk Score (CRS)
Detection cycle: 10 working days
Detection process: Testing Consultation > Informed Consent > Sample Collection > Sample Delivery Testing >
Analysis and Interpretation > Report Distribution
Contact
📍 11F, Building 2, DBH Life Sciences & Health Industrial Park 2028 Shenyan Road Yantian, Shenzhen, Guangdong 518000 China
深圳特趣生物科技有限公司
Copyright 2022
粤公网安备 44030802000618号